Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Lanreotid, ATC H01CB03 für die Zeit 01.07.2025 - 30.06.2026 (zzgl. Verlängerungsoption 1x 12 Monate)
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Contract value
- no value published
- Bids received
- 6
- Published
- 28 May 2026
- Awarded
- 1 Jul 2025
- Contract start
- 1 Jul 2025
- Contract end
- 19 Jul 2026estimated
- Region
- Hamburg